PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-129.30%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
7.42%
Positive gross profit growth while MTDR is negative. John Neff would see a clear operational edge over the competitor.
110.61%
Positive EBIT growth while MTDR is negative. John Neff might see a substantial edge in operational management.
110.61%
Positive operating income growth while MTDR is negative. John Neff might view this as a competitive edge in operations.
2444.00%
Positive net income growth while MTDR is negative. John Neff might see a big relative performance advantage.
2720.00%
Positive EPS growth while MTDR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
2720.00%
Positive diluted EPS growth while MTDR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
-0.03%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-50.00%
Dividend reduction while MTDR stands at 0.08%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-48.46%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-58.78%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-188.26%
Negative 10Y revenue/share CAGR while MTDR stands at 690.14%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-146.64%
Negative 5Y CAGR while MTDR stands at 1272.50%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-134.26%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
266.04%
10Y OCF/share CAGR under 50% of MTDR's 1566.28%. Michael Burry would worry about a persistent underperformance in cash creation.
69.02%
Below 50% of MTDR's 362.73%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-1.09%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
771.98%
Net income/share CAGR above 1.5x MTDR's 163.75% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-61.67%
Negative 5Y net income/share CAGR while MTDR is 139.65%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
16.21%
Positive short-term CAGR while MTDR is negative. John Neff would see a clear advantage in near-term profit trajectory.
346.73%
10Y equity/share CAGR 1.25-1.5x MTDR's 274.37%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
80.64%
Below 50% of MTDR's 204.54%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
14.39%
Below 50% of MTDR's 101.40%. Michael Burry suspects a serious short-term disadvantage in building book value.
956.98%
Dividend/share CAGR of 956.98% while MTDR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
405.76%
Dividend/share CAGR of 405.76% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
131.91%
Below 50% of MTDR's 529.33%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-38.57%
Firm’s AR is declining while MTDR shows 2.38%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-98.35%
Inventory is declining while MTDR stands at 23.07%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-36.14%
Negative asset growth while MTDR invests at 1.79%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-33.43%
We have a declining book value while MTDR shows 2.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-45.47%
We’re deleveraging while MTDR stands at 0.54%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-12.41%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.